{"id":38972,"date":"2026-11-08T10:57:16","date_gmt":"2026-11-08T15:57:16","guid":{"rendered":"https:\/\/www.diabete.qc.ca\/?p=38972"},"modified":"2026-11-08T11:07:52","modified_gmt":"2026-11-08T16:07:52","slug":"study-on-semaglutide-for-people-living-with-type-1-diabetes","status":"publish","type":"post","link":"https:\/\/www.diabete.qc.ca\/en\/news\/study-on-semaglutide-for-people-living-with-type-1-diabetes\/","title":{"rendered":"Study on semaglutide in people living with type 1 diabetes"},"content":{"rendered":"\n<p>The <strong>SEMAT1DBODY <\/strong>study by Dr. Pasqua is recruiting. The primary objective is to assess how semaglutide (versus placebo) changes body composition, especially lean mass, in people with T1D and BMI \u2265 27 kg\/m. Secondary goals are to assess other body composition subcategories, physical function (muscle strength and 6-minute walk), behaviours (step counting, food diary), metabolic control (glucose control, insulin needs, lipids), and patient-reported outcomes (questionnaires on diabetes and food intake). The study will also include an exploratory exercise sub-study to see if semaglutide (versus placebo) affects blood sugars and insulin needs during physical activity.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"791\" height=\"1024\" src=\"https:\/\/www.diabete.qc.ca\/wp-content\/uploads\/2026\/11\/Recruitment-poster_V1_EN_5FEB2025-791x1024.png\" alt=\"\" class=\"wp-image-38973\" srcset=\"https:\/\/www.diabete.qc.ca\/wp-content\/uploads\/2026\/11\/Recruitment-poster_V1_EN_5FEB2025-791x1024.png 791w, https:\/\/www.diabete.qc.ca\/wp-content\/uploads\/2026\/11\/Recruitment-poster_V1_EN_5FEB2025-232x300.png 232w, https:\/\/www.diabete.qc.ca\/wp-content\/uploads\/2026\/11\/Recruitment-poster_V1_EN_5FEB2025-768x994.png 768w, https:\/\/www.diabete.qc.ca\/wp-content\/uploads\/2026\/11\/Recruitment-poster_V1_EN_5FEB2025-1187x1536.png 1187w, https:\/\/www.diabete.qc.ca\/wp-content\/uploads\/2026\/11\/Recruitment-poster_V1_EN_5FEB2025-1583x2048.png 1583w, https:\/\/www.diabete.qc.ca\/wp-content\/uploads\/2026\/11\/Recruitment-poster_V1_EN_5FEB2025.png 1700w\" sizes=\"auto, (max-width: 791px) 100vw, 791px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>The SEMAT1DBODY study by Dr. Pasqua is recruiting. The primary objective is to assess how semaglutide (versus placebo) changes body composition, especially lean mass, in people with T1D and BMI \u2265 27 kg\/m. Secondary goals are to assess other body composition subcategories, physical function (muscle strength and 6-minute walk), behaviours (step counting, food diary), metabolic&hellip;<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"33274,24567,24583,30601,37386,24593","_relevanssi_noindex_reason":"","footnotes":""},"categories":[265],"tags":[],"class_list":["post-38972","post","type-post","status-publish","format-standard","hentry","category-non-classifiee-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/posts\/38972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/comments?post=38972"}],"version-history":[{"count":3,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/posts\/38972\/revisions"}],"predecessor-version":[{"id":38978,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/posts\/38972\/revisions\/38978"}],"wp:attachment":[{"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/media?parent=38972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/categories?post=38972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/tags?post=38972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}